Christopher Bissonnette

Managing Partner, Pallasite Ventures Inc.

📍 Vancouver, British Columbia, Canada🔄 Updated September 2026💼 10 investments📅 14 years investing🗓 Last invested Dec 2018
VC🌍 Canada
10
Total investments
5
Early stage
3
Mid stage
2
Late stage
14y
Years active

Portfolio

10 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Dec 2018
The IPM and Yield Forecasting Platform greenhouse growers trust. We are realistic dreamers and we work hard to ensure the world can benefit from food that is quality, reasonably priced, and pesticide free. Our mission is to help greenhouse growers get the visibility they need to protect their plants from pests and diseases before a pest or disease outbreak happens. We also give them the ability to measure their crop, forecast their yield, increase labour efficiency, and minimize production loss.
late stageFarming
Board Member
May 2018
Phoenix Molecular Designs is a clinical-stage biotechnology company that is developing small molecule kinase inhibitors as a targeted therapy for cancer. We are focused on treating one of the most aggressive types of breast cancer, Triple Negative Breast Cancer (TNBC), which currently has limited durable options. Our patented cancer compounds position us in the lead to fast track our product to market as it fills an unmet medical need. Our cancer therapy has the potential to save lives and improve quality of life.
Board Member
Sep 2017
Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform the treatment of currently incurable diseases. Aspect is creating these next generation cell therapies by applying its full-stack tissue therapeutic platform, which combines the company’s proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design. Aspect’s bioprinted tissue therapeutics are designed to replace, repair, or supplement biological function inside the body with the aim of treating currently incurable diseases such as type 1 diabetes as well as genetic and acquired liver diseases.
Board Member
May 2017
We build and maintain the website and digital marketing for your realty business, so you can stay connected with your clients—and attract new ones. As a team of marketers, engineers, and designers, we work together to give REALTORS® something they’ve never had before: The chance to market themselves online, and stand out, supported by the knowledge and tools only a team of experts can provide.
mid stageReal Estate
Board Member
May 2017
Ionomr Innovation produces revolutionary ion-exchange materials that represent a cost and efficiency breakthrough focused on hydrogen and CCU systems and more broadly new archetype of hydrocarbon (non-fluorinated/PFAS) membrane and ionomer materials for electrochemical systems. At Ionomr, we bridge the gap between materials science and real-world industrial problems and will help enable a large inflection of the global hydrogen, energy storage and sustainable chemical economies.
Board Member
Jan 2017
ViralGains is a marketing platform that enables brands to discover, understand and nurture new and returning customers by leveraging zero-party data via interactive ads, surveys, and audience building technology to support brand-defined strategies. ViralGains is headquartered in Bostons Innovation District, with regional offices in New York, Chicago, Detroit, San Francisco, Atlanta, and Los Angeles. For more information, please contact us at www.viralgains.com.
Board Member
Jun 2015
HyprLoco is a location intelligence company solving the line management challenges for the Quick Service Restaurant industry. This is done by connecting the customer's location with their mobile order in real-time to deliver the "Best Day Ever"​ experience. Contact us today for a demo: info@hyprloco.com
Board Observer
Jul 2014
ViralGains is a marketing platform that enables brands to discover, understand and nurture new and returning customers by leveraging zero-party data via interactive ads, surveys, and audience building technology to support brand-defined strategies. ViralGains is headquartered in Bostons Innovation District, with regional offices in New York, Chicago, Detroit, San Francisco, Atlanta, and Los Angeles. For more information, please contact us at www.viralgains.com.
Board Member
Aug 2012
GreenSigns is a digital billboard company that reaches the most desirable Chicago suburban commuters. Our large format digital displays are state-of-the-art high-resolution spectaculars that are located in heavily traveled and high demand business corridors. And we offer a mix of some of the most iconic and well know Chicago wall and static spectaculars.
Board Member
May 2012
Data Driven Intelligence for Smart Cities. CityScan, a Chicago venture-backed software company, is leading the field in intelligent data collection and integration for Smart Cities and Utilities. Our patented process integrates private and municipal data with the most advanced 3D visual data collection methods available, resulting in improved efficiency operations while reducing overall costs. Our technology provides clients a solution to manage their assets, ensure businesses are operating within local ordinances and provide a safe environment for their residents.
Experience · 13 entries
All (13)
Investments (10)
Founder (1)
Board (10)
2018
Board Member
Dec 2018
The IPM and Yield Forecasting Platform greenhouse growers trust. We are realistic dreamers and we work hard to ensure the world can benefit from food that is quality, reasonably priced, and pesticide free. Our mission is to help greenhouse growers get the visibility they need to protect their plants from pests and diseases before a pest or disease outbreak happens. We also give them the ability to measure their crop, forecast their yield, increase labour efficiency, and minimize production loss.
late stageFarming
Board Member
May 2018
Phoenix Molecular Designs is a clinical-stage biotechnology company that is developing small molecule kinase inhibitors as a targeted therapy for cancer. We are focused on treating one of the most aggressive types of breast cancer, Triple Negative Breast Cancer (TNBC), which currently has limited durable options. Our patented cancer compounds position us in the lead to fast track our product to market as it fills an unmet medical need. Our cancer therapy has the potential to save lives and improve quality of life.
2017
Board Member
Sep 2017
Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform the treatment of currently incurable diseases. Aspect is creating these next generation cell therapies by applying its full-stack tissue therapeutic platform, which combines the company’s proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design. Aspect’s bioprinted tissue therapeutics are designed to replace, repair, or supplement biological function inside the body with the aim of treating currently incurable diseases such as type 1 diabetes as well as genetic and acquired liver diseases.
Board Member
May 2017
We build and maintain the website and digital marketing for your realty business, so you can stay connected with your clients—and attract new ones. As a team of marketers, engineers, and designers, we work together to give REALTORS® something they’ve never had before: The chance to market themselves online, and stand out, supported by the knowledge and tools only a team of experts can provide.
mid stageReal Estate
Board Member
May 2017
Ionomr Innovation produces revolutionary ion-exchange materials that represent a cost and efficiency breakthrough focused on hydrogen and CCU systems and more broadly new archetype of hydrocarbon (non-fluorinated/PFAS) membrane and ionomer materials for electrochemical systems. At Ionomr, we bridge the gap between materials science and real-world industrial problems and will help enable a large inflection of the global hydrogen, energy storage and sustainable chemical economies.
Show all 13 entries ↓
Investment activity
2012–2018 · 10 investments
2012220141201512017420182
Recent (last 2 years)Earlier